Literature DB >> 30366769

The KIF5B-RET Fusion Gene Mutation as a Novel Mechanism of Acquired EGFR Tyrosine Kinase Inhibitor Resistance in Lung Adenocarcinoma.

You-Cai Zhu1, Wen-Xian Wang2, Qu-Xia Zhang3, Chun-Wei Xu4, Wu Zhuang5, Kai-Qi Du1, Gang Chen6, Tang-Feng Lv7, Yong Song7.   

Abstract

Entities:  

Keywords:  Acquired resistance; EGFR gene; KIF5B-RET; Lung adenocarcinoma; Novel mechanism

Mesh：

Substances：

Year:  2018        PMID： 30366769     DOI： 10.1016/j.cllc.2018.09.011

Source DB:  PubMed          Journal:  Clin Lung Cancer        ISSN： 1525-7304            Impact factor:   4.785


× No keyword cloud information.
  5 in total

1.  The potential and limitation of targeted chromosomal breakpoint sequencing for the ROS1 fusion gene identification in lung cancer.

Authors:  Ming-Szu Hung; Yu-Ching Lin; Fen-Fen Chen; Yuan-Yuan Jiang; Yu-Hung Fang; Ming-Shian Lu; Chin-Kuo Lin; Tsung-Ming Yang; Jrhau Lung; Chih-Cheng Chen; Kuan-Der Lee; Ying-Huang Tsai
Journal:  Am J Cancer Res       Date:  2022-05-15       Impact factor: 5.942

2.  Response to Pralsetinib Observed in Meningeal-Metastatic EGFR-Mutant NSCLC With Acquired RET Fusion: A Brief Report.

Authors:  Zichen Zhao; Chao Su; Weigang Xiu; Weiya Wang; Shasha Zeng; Meijuan Huang; Youling Gong; You Lu; Yan Zhang
Journal:  JTO Clin Res Rep       Date:  2022-05-19

3.  Emerging a Novel VOPP1-EGFR Fusion Coexistent With T790M as an Acquired Resistance Mechanism to Prior Icotinib and Sensitive to Osimertinib in a Patient With EGFR L858R Lung Adenocarcinoma: A Case Report.

Authors:  Xia Wang; Weiwei Peng; Zhimin Zeng; Jing Cai; Anwen Liu
Journal:  Front Oncol       Date:  2021-12-22       Impact factor: 6.244

4.  The Landscape of Novel Expressed Chimeric RNAs in Rheumatoid Arthritis.

Authors:  Rajesh Detroja; Sumit Mukherjee; Milana Frenkel-Morgenstern
Journal:  Cells       Date:  2022-03-24       Impact factor: 6.600

5.  An autophagy-related model of 4 key genes for predicting prognosis of patients with laryngeal cancer.

Authors:  Meng-Si Luo; Guan-Jiang Huang; Hong-Bing Liu
Journal:  Medicine (Baltimore)       Date:  2020-07-24       Impact factor: 1.817
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.